Financials data is unavailable for this security.
Cash flow in CNYView more
In 2023, Hua Medicine increased its cash reserves by 197.74%, or 970.19m. The company earned 889.37m from its operations for a Cash Flow Margin of 1,160.90%. In addition the company generated 8.08m and 69.07m cash from investing and financing, respectively.
Cash flow per share | -0.2525 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.0368 |
---|---|
Tangible book value per share | -0.0673 |
More ▼
Balance sheet in CNYView more
Current ratio | 4.87 |
---|---|
Quick ratio | 4.64 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 1.14 |
More ▼